Amgen Inc (AMGN)
294.52
+4.62
(+1.59%)
USD |
NASDAQ |
Nov 22, 16:00
294.53
+0.01
(+0.00%)
After-Hours: 20:00
Amgen Revenue (TTM): 32.53B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 32.53B |
| June 30, 2024 | 30.93B |
| March 31, 2024 | 29.53B |
| December 31, 2023 | 28.19B |
| September 30, 2023 | 26.83B |
| June 30, 2023 | 26.58B |
| March 31, 2023 | 26.19B |
| December 31, 2022 | 26.32B |
| September 30, 2022 | 26.33B |
| June 30, 2022 | 26.38B |
| March 31, 2022 | 26.32B |
| December 31, 2021 | 25.98B |
| September 30, 2021 | 25.77B |
| June 30, 2021 | 25.48B |
| March 31, 2021 | 25.16B |
| December 31, 2020 | 25.42B |
| September 30, 2020 | 24.99B |
| June 30, 2020 | 24.30B |
| March 31, 2020 | 23.97B |
| December 31, 2019 | 23.36B |
| September 30, 2019 | 23.40B |
| June 30, 2019 | 23.56B |
| March 31, 2019 | 23.75B |
| December 31, 2018 | 23.75B |
| September 30, 2018 | 23.32B |
| Date | Value |
|---|---|
| June 30, 2018 | 23.19B |
| March 31, 2018 | 22.94B |
| December 31, 2017 | 22.85B |
| September 30, 2017 | 23.01B |
| June 30, 2017 | 23.05B |
| March 31, 2017 | 22.93B |
| December 31, 2016 | 22.99B |
| September 30, 2016 | 22.56B |
| June 30, 2016 | 22.47B |
| March 31, 2016 | 22.16B |
| December 31, 2015 | 21.66B |
| September 30, 2015 | 21.46B |
| June 30, 2015 | 20.76B |
| March 31, 2015 | 20.58B |
| December 31, 2014 | 20.06B |
| September 30, 2014 | 19.74B |
| June 30, 2014 | 19.46B |
| March 31, 2014 | 18.96B |
| December 31, 2013 | 18.68B |
| September 30, 2013 | 18.09B |
| June 30, 2013 | 17.66B |
| March 31, 2013 | 17.46B |
| December 31, 2012 | 17.26B |
| September 30, 2012 | 16.82B |
| June 30, 2012 | 16.44B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
23.36B
Minimum
Dec 2019
32.53B
Maximum
Sep 2024
26.53B
Average
26.25B
Median
Revenue (TTM) Benchmarks
| Johnson & Johnson | 87.70B |
| Eli Lilly and Co | 40.86B |
| Merck & Co Inc | 63.17B |
| Regeneron Pharmaceuticals Inc | 13.85B |
| Viking Therapeutics Inc | -- |